"Please do not call our hospitals or your doctor's office to schedule a COVID-19 vaccination. We're following CDC and state guidelines with a phased approach that prioritizes those most vulnerable. If you're our patient, we'll email, call or text you directly to schedule your vaccination when you become eligible and it's your turn to get vaccinated based on available supplies."

During the past decade, Aurora BayCare Medical Center conducted 152 clinical trials. In the 10-year time frame, 152 clinical trials started and 92 clinical trials were completed, i.e. on average, 60.5% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 71 clinical trials were completed. i.e. 122.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aurora BayCare Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 91 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "NRG Oncology" with 20 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aurora BayCare Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 112 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "Genentech, Inc." with 5 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Aurora BayCare Medical Center" are "Breast Cancer" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (9 trials) and "Primary Peritoneal Serous Adenocarcinoma" (8 trials). Many other conditions were trialed in "Aurora BayCare Medical Center" in a lesser frequency.

Most popular intervention types in "Aurora BayCare Medical Center" are "Drug" (170 trials), "Other" (143 trials), "Biological" (79 trials), "Procedure" (54 trials) and "Radiation" (51 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (68 trials), "Quality-of-Life Assessment" (68 trials), "Questionnaire Administration" (40 trials), "Paclitaxel" (31 trials) and "Carboplatin" (27 trials). Other intervention names were less common.

The vast majority of trials in "Aurora BayCare Medical Center" are 164 trials for "All" genders, 55 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Aurora BayCare Medical Center". undefined are not yet recruiting, 51 are recruiting, 117 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Aurora BayCare Medical Center, 6 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Aurora BayCare Medical Center, 4 "Phase 1" clinical trials were conducted, 90 "Phase 2" clinical trials and 135 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".